Cresco Labs Earnings + Call Notes
U.S. cannabis leader shares Q423 results.
$188.2M Revs; est. $181.6M
$54.8M AEBITDA: est. $43.9M
$96.1M GP; est. $89.6M
$27.1M OI; est. $25.3M
51.1% GM; est. 49.4%
$4.9M NI; est. ($7.1M)
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.